Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus by Björkström, Niklas K. et al.
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 208 No. 1  13-21
www.jem.org/cgi/doi/10.1084/jem.20100762
13
Brief Definitive Report
Several experimental models have demonstrated 
a role for NK cells in host responses against   
virus infections (Lodoen and Lanier, 2006; Lee   
et al., 2007). The perhaps most well character-
ized experimental model system in this respect 
is that of infection of mice with mouse CMV 
(Dokun et al., 2001; Lodoen and Lanier, 2006; 
Sun et al., 2009). In experimental mouse CMV 
infection, the NK cell response is characterized 
by proliferation of a specific subset of NK cells 
that  peaks  within  a  few  days  after  infection. 
Subsequently, this NK cell population undergoes 
rapid contraction by apoptosis (Dokun et al., 
2001; Robbins et al., 2004). To investigate more 
directly how results from studies of viral infec-
tions in experimental model systems compare 
with infections in humans, we have studied the 
NK cell response throughout the course of an 
acute virus infection in humans.
In humans, involvement of NK cells in host 
responses to viruses were first indicated by the 
finding  that  virus-induced  IFN-  enhanced 
NK cell–mediated cytotoxicity (Santoli et al., 
1978; Trinchieri et al., 1978). Subsequently, low 
NK cell cytotoxic activity was linked to in-
creased sensitivity to severe disseminating her-
pesvirus  infections  (Ching  and  Lopez,  1979; 
Quinnan et al., 1982; Merino et al., 1986; Joncas 
et al., 1989). NK cell defects were also shown   
to occur at chronic stages of HIV infection 
(Bonavida et al., 1986; Katz et al., 1987). Perhaps 
the most convincing data, however, for a role of 
NK cells in host responses to viral infections   
in humans has come from studies of patients 
with primary immunodeficiencies affecting NK 
cell numbers and/or NK cell function (Biron   
et al., 1989; Orange, 2006; Bryceson et al., 2007). 
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Natural killer (NK) cells are known to mount a rapid response to several virus infections.  
In experimental models of acute viral infection, this response has been characterized by 
prompt NK cell activation and expansion followed by rapid contraction. In contrast to experi-
mental model systems, much less is known about NK cell responses to acute viral infections in 
humans. We demonstrate that NK cells can rapidly expand and persist at highly elevated 
levels for >60 d after human hantavirus infection. A large part of the expanding NK cells 
expressed the activating receptor NKG2C and were functional in terms of expressing a licens-
ing inhibitory killer cell immunoglobulin-like receptor (KIR) and ability to respond to target 
cell stimulation. These results demonstrate that NK cells can expand and remain elevated in 
numbers for a prolonged period of time in humans after a virus infection. In time, this re-
sponse extends far beyond what is considered normal for an innate immune response.
© 2011 Björkström et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first 
six  months  after  the  publication  date  (see  http://www.rupress.org/terms).   
After six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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total NK cells, and individual NK cell subsets were deter-
mined at days 5 and 60 after the onset of symptoms. Surprisingly, 
at day 60 after onset of symptoms, total lymphocyte numbers 
were increased approximately twofold compared with those 
on day 5 (Fig. 1 a). Among lymphocytes, NK cell numbers   
increased three- to fourfold (Fig. 1, b and c). When specific NK 
cell subsets were studied, the numbers of CD56dim and atypical   
CD56neg (Gonzalez et al., 2009; Björkström et al., 2010b) NK   
cells had increased markedly, whereas the numbers of CD56bright 
NK cells did not change significantly (Fig. 1, d and e). The in-
creases in absolute numbers of NK cells correlated well with 
heightened frequencies of total NK cells (Fig. S2 a) and spe-
cific NK cell subpopulations (Fig. S2 b).
These initial findings prompted us to perform a more de-
tailed kinetic analysis of the increase in CD56dim NK cell 
numbers  at  the  acute  phase  of  hantavirus  infection  and 
throughout the convalescent period until 15 mo after onset of 
disease. After initial low NK cell numbers, possibly as a result 
of extravasation into tissues during the acute phase of infec-
tion (Terajima et al., 2007; Schönrich et al., 2008), NK cell 
numbers increased markedly and peaked at around 10 d after 
the onset of symptoms. CD56dim NK cell numbers then re-
mained elevated for at least 60 d (Fig. 2 a). At 15 mo after   
infection, CD56dim NK cell numbers had declined to those   
in uninfected controls (Fig. 2 a).
Increased NK cell numbers is a direct consequence  
of induced proliferation
To determine whether the increased numbers of CD56dim 
NK cells was a consequence of NK cell proliferation or, alter-
natively (but perhaps less likely), NK cell recruitment to the 
blood, expression of the proliferation marker Ki67 (Gerdes   
et al., 1984) was analyzed in the CD56dim NK cell population. 
Compared with uninfected individuals, where Ki67 expres-
sion is low in a majority of CD56dim NK cells, up to 50% of 
the CD56dim NK cells expressed Ki67 during the first 10 d of 
In addition, several studies have described different character-
istics of NK cells in patients with chronic viral infections 
(Fauci et al., 2005; Rehermann and Nascimbeni, 2005). How-
ever, few studies have more directly followed the human   
NK cell response throughout an acute virus infection.
The opportunity to do so accompanied a Puumala hanta-
virus outbreak that occurred in Northern Sweden during 2007 
(Pettersson et al., 2008). In humans, Puumala hantaviruses cause 
hemorrhagic fever with renal syndrome, a disease characterized 
by severe symptoms with occasional mortalities which stem 
from capillary leakage (Vapalahti et al., 2003; Schönrich et al., 
2008). In infected individuals, virus replication has been docu-
mented in vascular endothelium, but the virus does not seem 
to cause direct cytopathic effects (Schönrich et al., 2008). The 
ensuing viremia that develops is normally cleared within 1–2 
wk after the onset of symptoms (Schönrich et al., 2008). Dur-
ing the course of the present Puumala hantavirus outbreak, we 
prospectively collected clinical samples and followed NK cell 
responses in 16 patients from their first presentation at the 
emergency unit with acute symptoms until up to 15 mo after 
symptom debut. This enabled us to investigate in detail the NK 
cell response in virally infected humans, from the very first days 
of clinical symptoms until resolution of disease and beyond.
The results show that NK cells, in a majority of the stud-
ied patients, rapidly expand and remain at significantly ele-
vated numbers for >2 mo thereafter. Possible mechanisms 
behind this finding were investigated and the functionality of 
responding cells was determined. The results are discussed in 
relation to NK cell memory and the possible role of previous 
virus infections the present responses.
RESULTS AND DISCUSSION
NK cells rapidly expand and persist at elevated levels during 
acute hantavirus infection in humans
In blood samples from 16 patients infected with hantavirus 
(Table S1 and Fig. S1), absolute numbers of total lymphocytes, 
Figure 1.  Increase in CD56dim NK cells in 
human hantavirus infection. PBMCs from 
patients with acute hantavirus infection were 
analyzed by flow cytometry. (a and b) Abso-
lute numbers of lymphocytes (a) and NK cells 
(b) at days 5 and 60 after symptom debut.  
(c) Relative changes of total lymphocytes and 
NK cells from days 5–60 after symptom  
debut (mean ± SEM). (d) Definition of  
CD56brightCD16 (i), CD56brightCD16+ (ii),  
CD56dimCD16+ (iii), and CD56CD16+ (iv) NK 
cells by flow cytometry from one representative 
patient with acute hantavirus infection. Cells 
were gated on the CD3CD4CD14CD19 
population within the single cell lymphocyte 
gate. (e) Absolute numbers of the different NK 
cell subsets at days 5 and 60. For a–e, n = 16. 
*, P < 0.05; **, P < 0.01; ***, P < 0.0001, paired 
Student’s t test.JEM VOL. 208, January 17, 2011  15
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elevated up to 60 d after disease onset in most of the hantavi-
rus-infected  patients  (Fig.  2  f).  In  contrast,  levels  of  IL-2,   
IL-12, or IFN- were not significantly altered in the infected 
patients over time (Fig. S3). Thus, the increased plasma levels 
of IL-15 could likely contribute to the observed CD56dim 
NK cell proliferation.
IL-15 may, however, not only contribute to NK cell pro-
liferation but may also play a dominant role in promoting the 
survival of proliferating NK cells (Rodella et al., 2001). This 
may, at least in part, occur via up-regulation of the antiapop-
totic molecule Bcl-2 (Prlic et al., 2003; Ranson et al., 2003). 
Therefore, we studied Bcl-2 expression in proliferating NK 
cells in hantavirus-infected patients and compared the results 
with observations in CD8 T cells. Indeed, consistent with 
published observations (Miller et al., 2008), we found that 
clinical symptoms after hantavirus infection (Fig. 2, b and c). 
Subsequently,  the  proportion  of  Ki67-expressing  CD56dim 
NK cells declined, both with respect to relative frequencies 
and in absolute numbers (Fig. 2, d and e). Interestingly, the 
decline in frequency of Ki67+ NK cells was temporarily asso-
ciated with the decline in viral load (Fig. S1).
IL-15 and Bcl-2 are required for NK cell proliferation  
and persistence
To identify possible factors contributing to NK cell prolifera-
tion  and  persistence,  we  first  determined  levels  of  plasma   
cytokines known to support NK cell proliferation and ho-
meostasis. One key cytokine in this respect is IL-15 (Prlic   
et  al.,  2003;  Ranson  et  al.,  2003;  Becknell  and  Caligiuri,   
2005). Interestingly, we found that plasma levels of IL-15 were   
Figure 2.  Rapid proliferation and sustained elevation of CD56dim NK cell numbers. (a) Numbers of CD56dimCD16+ NK cells (solid lines) evaluated 
longitudinally from day 5 until day 450 after onset of clinical symptoms in infected patients (n = 16) and uninfected controls (n = 26; **, P < 0.01, Mann-
Whitney test; mean ± SEM; the dashed lines represent upper and lower SEM intervals for mean of CD56dimCD16+ NK cells in the control individuals).  
(b–e) Expression of intracellular Ki67 used as an indicator of cells that are dividing or have recently divided. (b) Representative examples of Ki67 expres-
sion in CD56dim NK cells analyzed by flow cytometry at days 5, 11, and 60 after onset of symptoms in one hantavirus-infected patient. (c) Frequency of 
Ki67-positive cells in controls (n = 5) and patients 5 d after symptoms debut (n = 6; **, P = 0.0043, Mann-Whitney test; mean ± SEM). (d and e) Frequency 
(d) and absolute numbers (e) of Ki67+ CD56dim NK cells evaluated longitudinally in the infected patients (n = 8; mean ± SEM). (f) Plasma levels of IL-15 in 
the hantavirus-infected patients (n = 16) and noninfected controls (n = 24). IL-15 levels were significantly increased during acute infection compared 
with the convalescent stage (day 450; **, P < 0.01, Mann-Whitney test; mean ± SEM). (g and h) Expression of Bcl-2 in CD8 T cells and NK cells from pa-
tients with acute hantavirus infection analyzed by flow cytometry. Representative staining of Ki67 and Bcl-2 on CD8 T cells (g) and CD56dim NK cells  
(h) from one patient at day 5 after onset of symptoms, as well as the mean expression level (MFI) of Bcl-2 in Ki67+ and Ki67 CD8 T cells (g) and CD56dim 
NK cells (h) at days 5, 11, and 450 after onset of symptoms (n = 8; *, P < 0.05, Mann-Whitney test; horizontal bars represent mean).16 Human NK cell response to acute hantavirus infection | Björkström et al.
Timonen, 1997). Furthermore, in NK cells, ICAM-1–LFA-1 
interactions contribute to NK cell activation and are critical 
for polarization of NK cell lytic granules toward target cells 
(Bryceson et al., 2005). In contrast to ICAM-1, infected human 
endothelial cells did not show any marked up-regulation of 
ligands for NKG2D (MICA, MICB, or ULBP1-4) or DNAM-1 
(CD112 or CD155). However, a significant up-regulation of 
HLA-E was observed (Fig. 3 c). This was interesting because 
HLA-E is a ligand for the activating NK cell receptor NKG2C 
(Braud et al., 1998), which has been previously implicated in 
host  responses  to  CMV-infected  cells  (Gumá  et  al.,  2004; 
Kuijpers et al., 2008).
Human CMV encodes UL40, a protein which in its signal 
sequence has a peptide motif identical to that of several HLA 
class I signal sequences which binds to and stabilizes HLA-E 
(Tomasec et al., 2000). To address whether a similar mecha-
nism for increased expression of HLA-E exits in hantavirus-
infected cells, we searched predicted HLA-E binding peptides 
motifs in the hantavirus proteins. Although we did identify 
one such peptide, this peptide did not stabilize HLA-E ex-
pression in vitro (unpublished data). Thus, virus-encoded 
HLA-E–binding peptides are a less likely explanation for the 
induced HLA-E expression. As HLA-E is dependent on sig-
nal sequences from other HLA class I molecules for its ex-
pression, another possible explanation for the up-regulation 
of HLA-E in hantavirus-infected cells is via an indirect mech-
anism linked to induced expression of classical HLA class I mol-
ecules. To test this hypothesis, we analyzed infected endothelial 
proliferating (Ki67+) CD8  T cells expressed significantly lower 
levels of Bcl-2 compared with nonproliferating (Ki67) CD8 
T cells (Fig. 2 g). In contrast, proliferating (Ki67+) NK cells ex-
pressed elevated levels of Bcl-2 compared with nonproliferating 
(Ki67) NK cells (Fig. 2 h). These data suggest that Bcl-2 up-
regulation may prevent early apoptosis of proliferating NK cells 
and contribute to an accumulation of these cells in the course 
of the infection and, possibly, even beyond its resolution.
Hantavirus-infected endothelial cells up-regulate  
the NKG2C-ligand HLA-E
Specific NK cell activation receptors have been shown to ex-
hibit important roles in stimulating proliferation and contrib-
uting to the control of viral infections in experimental model 
systems (Dokun et al., 2001; Mandelboim et al., 2001; Arase   
et al., 2002; Gazit et al., 2006; Sun et al., 2009). These recep-
tors have in common that they may recognize virus-associated 
and/or induced-self molecules on infected cells (Bryceson et al., 
2006). To identify candidate NK cell activation receptors that 
might be of importance in recognition of target cells during 
human hantavirus infection, we infected primary human en-
dothelial cells with hantavirus to assess changes in NK cell re-
ceptor-ligand expression (Fig. 3, a and b). In the course of 
these studies, we first observed an up-regulation of intercellu-
lar adhesion molecule (ICAM) 1, a ligand for lymphocyte 
function-associated antigen 1 (LFA-1), on infected endothelial 
cells (Fig. 3 c). LFA-1 has a well established role in promoting 
lymphocyte adhesion to endothelial cells (Robertson et al., 1990; 
Figure 3.  Hantavirus-infected endothelial cells up-regulate HLA-E. (a and b) Expression of ligands for NK cell receptors analyzed on hantavirus-
infected primary human umbilical vein endothelial cells. (a) Immunofluorescence staining with patient serum on uninfected and infected cells 24 and 48 h 
after infection (hpi). Original magnification, 40×. Bars, 20 µm. (b) Kinetics of infection of endothelial cells. (c and d) Expression of ligands for NKG2D, 
NKG2A/C, DNAM-1, LFA-1, and KIRs assessed on infected (dashed lines) and uninfected (solid lines) endothelial cells 72 h after infection. Shaded histo-
grams represent isotype control stainings. Co-culture of endothelial cells with UV-inactivated hantavirus for 72 h did not alter the expression of these 
ligands compared with uninfected cells (not depicted). Data in a–d are representative of three separate experiments.JEM VOL. 208, January 17, 2011  17
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response to human hantavirus-infected cells. Strikingly, we 
observed that the hantavirus-infected patients exhibited a three- 
to fourfold increase in the frequency of NKG2C+ NK cells al-
ready at day 5 compared with uninfected controls (Fig. 4 a).   
This observation could not be explained by cytokine-induced 
up-regulation of NKG2C expression on NKG2C cells (un-
published data). In contrast, NKG2A (an inhibitory receptor 
binding to HLA-E) was present at a lower frequency at day 5 
in the infected patients than in uninfected healthy subjects 
(unpublished  data).  Furthermore  the  expanded  NKG2C+ 
NK cells did not co-express NKG2A (Fig. 4, b and c). When 
longitudinally assessing the numbers of NKG2C+ NK cells in 
infected patients, we observed an expansion and persistence 
of NKG2C+ NK cells for a prolonged period of time (Fig. 4 d). 
This specific expansion of NKG2C+ cells did account for a 
significant part of the overall NK cell expansion observed 
cells for expression of classical HLA class I molecules. Indeed, 
we did observe increased expression of classical HLA class I 
molecules  in  the  infected  cells,  including  HLA-A2  and   
HLA-C (Fig. 3 d). These may contribute peptide cargo for 
HLA-E, leading to increased cell surface expression (Braud   
et al., 1998). Additionally, it cannot be excluded that cyto-
kines produced during the infection may also directly affect   
HLA-E expression.
Expanding and persisting NK cells are confined  
to an NKG2C-expressing subset
Because HLA-E is a ligand for the activating NK cell receptor 
NKG2C (Braud et al., 1998), which has been previously im-
plicated in host responses to virus-infected cells (Gumá et al., 
2004; Kuijpers et al., 2008), we examined more directly if this 
receptor might be involved in regulation of the NK cell   
Figure 4.  Expansion of NKG2C+ NK cells.  
(a) Frequency of NKG2C+ cells within the CD56dim NK 
cell population on day 5 after onset of symptoms  
in hantavirus-infected patients compared with non-
infected controls (n = 16 infected, 59 uninfected;  
***, P < 0.0001, unpaired Student’s t test; mean).  
(b) Representative example of costaining for NKG2A 
and NKG2C on CD56dim NK cells in hantavirus- 
infected patient at day 5 after onset of symptoms.  
(c) Co-expression of NKG2C and NKG2A evaluated  
at day 5 in infected (n = 6) and uninfected control  
(n = 9) individuals (horizontal bars represent  
mean). (d) Numbers of NKG2C+, NKG2A+, and 
NKG2CNKG2A CD56dimCD16+ NK cells evaluated 
longitudinally from day 5 until day 450 after onset of 
symptoms in infected patients (n = 6; mean ± SEM). 
Dashed lines represent the upper and lower SEM 
intervals for mean of NKG2C+ NK cell numbers in 
control individuals (n = 26). (e) Representative ex-
ample of costaining for NKG2C and CD57 on CD56dim 
NK cells in one hantavirus-infected patient at day 60 
after onset of symptoms. (f) Expression of CD57 eval-
uated at day 60 after symptom debut (n = 6) in 
NKG2C+ and NKG2C CD56dim NK cells (**, P = 
0.0022, Mann-Whitney test; mean). (g) Proliferation 
of NKG2C+ NK cells after stimulation with IL-15 and/
or target cells measured by dilution of CellTrace vio-
let. Purified NK cells were incubated for 7 d with or 
without irradiated K562 cells or K562*HLA-E cells, 
and in the absence (top) or presence (bottom) of  
IL-15. One representative experiment out of two is 
shown. (h) Expression pattern of the three major KIRs 
on NKG2C+ and NKG2C NK cells. In one representa-
tive donor, a majority of the NKG2C+ NK cells were 
single positive for KIR2DL1/S1 (top), whereas the 
second representative donor shows a selective ex-
pression of KIR2DL2/S2/2DL3 (bottom) in the NKG2C+ 
population (see Fig. S4 for separation between acti-
vation and inhibitory KIRs). Two representative do-
nors out of five analyzed are shown. (i) Degranulation 
and cytokine production responses quantified in NKG2C+ CD56dim NK cells from patients in the convalescent phase of infection after triggering with 
K562-E cells with or without addition of an HLA-E stabilizing peptide (n = 5; *, P < 0.05, Mann-Whitney test). (j) Absolute numbers of NKG2C+ CD56dim NK 
cells in CMV IgG and IgG+ infected individuals at day 5 (mean ± SEM).18 Human NK cell response to acute hantavirus infection | Björkström et al.
a single licensing KIR on a dominant proportion of NKG2C+ 
cells in some of the patients studied is interesting, as it resem-
bles some degree of clonality in the response. The driving 
forces behind this pattern are unknown.
To address functionality of the NKG2C+ NK cells di-
rectly, we stimulated patient NK cells with K562 cells that 
had been transfected with HLA-E. HLA-E was stabilized on 
the surface by adding an HLA-E–stabilizing peptide. Stimulation 
of NKG2C+ NK cells with HLA-E–expressing target cells 
increased degranulation, as well as IFN- and TNF production, 
both quantitatively and qualitatively (Fig. 4 i and not depicted). 
These results demonstrate a skewing of the NK cell compart-
ment with the accumulation of numerous licensed multi-
functional NKG2C+ NK cells after hantavirus infection.
CMV infection and NKG2C+ NK cell expansion  
in hantavirus infection
Most humans are infected with CMV, an infection normally 
occurring early in life which is associated with establishment 
of latency and sporadic reactivations. CMV seropositivity has 
been associated with higher frequencies of NKG2C+ NK 
cells in peripheral blood as compared with frequencies in un-
infected (CMV seronegative) individuals (Gumá et al., 2004; 
Kuijpers et al., 2008). We therefore addressed if the elevated 
levels of NKG2C+ NK cells in hantavirus-infected patients 
could be explained by CMV reactivation. However, we did 
not detect any CMV DNA in plasma from infected patients, 
and the absolute numbers of CD8 T cells specific for the 
CMV pp65 epitope were not altered throughout the course 
of hantavirus infection (unpublished data). Thus, we have   
no evidence supporting the possibility that the increase in 
NKG2C+ NK cells could be a result of CMV reactivation 
during human hantavirus infection. However, it is notewor-
thy that 3 out of 16 patients included in the present cohort 
were  CMV  IgG  negative.  Interestingly,  these  patients  had 
lower absolute numbers of NKG2C+ NK cells than the ma-
jority of patients being CMV IgG positive at day 5, and no 
subsequent expansion occurred in the IgG-negative patients 
(Fig. 4 j). Based on this small number of patients, the possibil-
ity arises that previous CMV infection may have primed a 
population of NKG2C+ NK cells for efficient expansion after 
hantavirus infection (Cooper et al., 2009; Sun et al., 2009). 
This intriguing possibility needs to be addressed further in 
future studies, pending the emergence of new epidemics and 
availability of similar clinical material.
Conclusions
The proliferation of a specific subset of NKG2C+ NK cells in 
a majority of patients infected with hantavirus in humans re-
sembles results described in experimental models of CMV 
infection where Ly49H+ NK cells rapidly expand as a conse-
quence of infection (Dokun et al., 2001; Robbins et al., 2004; 
Sun et al., 2009). However, distinct from what has been ob-
served in mouse models, the expansion of NKG2C+ NK cells 
was maintained for >60 d. Consistent with previous reports 
on NK cell memory-like features in mice (O’Leary et al., 2006; 
within the course of this infection. Phenotypically, a predomi-
nant proportion of these NKG2C+ cells expressed CD57 after 
expansion (Fig. 4, e and f), indicating that they may represent 
highly mature and, possibly, terminally differentiated CD56dim 
NK cells (Björkström et al., 2010c; Lopez-Vergès et al., 2010).
Cytokines, such as IL-15, may likely contribute to expan-
sion of NK cells. In support of this notion, studies in human-
ized  mice  have  shown  that  trans-presentation  of  IL-15  is 
crucial for the development and proliferation of human NK 
cells (Ranson et al., 2003; Huntington et al., 2009; Strowig   
et al., 2010). A recent study also demonstrated a dramatic ex-
pansion of NK cells (and memory CD8 T cells) in the circu-
lation of the rhesus macaques given IL-15 (Lugli et al., 2010). 
However, it is more difficult to envisage how cytokines such 
as IL-15 could drive a specific subpopulation of NK cells, un-
less these harbor specific memory characteristics (Cooper et al., 
2009; Sun et al., 2009). To address if cytokines, directly or in 
combination with target cell recognition, could lead to ex-
pansion of NKG2C+ NK cells ex vivo, we exposed NKG2C+ 
NK cells to IL-15 in the absence or presence of target ex-
pressing HLA-E ligands. Exposure of NKG2C+ NK cells to 
IL-15 did not suffice to induce significant proliferation of the 
cells (Fig. 4 g). However, simultaneous exposure to IL-15 and 
target cells expressing HLA-E led to a marked proliferative 
response of the NKG2C+ NK cells (Fig. 4 g). Thus, based on 
these studies, it is possible that recognition of infected target 
cells in the presence of IL-15 might have contributed to the 
expansion of NKG2C+ NK cells observed in hantavirus- 
infected patients.
Expanding NKG2C+ NK cells are licensed and functionally 
competent cells
The data presented thus far demonstrate a significant expan-
sion of predominantly NKG2C+ CD56dim NK cells during 
acute hantavirus infection but do not disclose the functional 
capacity of the expanded cells. To address this, we determined 
the licensing status by inhibitory killer cell Ig-like receptor 
(KIR)/HLA expression (Kim et al., 2005; Anfossi et al., 2006) 
and  functionality  of  the  expanding  cells  upon  stimulation 
with target cells expressing HLA-E.
NK cells expressing inhibitory receptors for self-MHC 
class I molecules are rendered licensed, that is, functionally 
more responsive to stimulation (Kim et al., 2005; Anfossi   
et al., 2006). In five patients examined in detail, the NKG2C+ 
NK cells uniformly expressed a single inhibitory HLA-C 
binding KIR (Fig. 4 h; and Fig. S4, a and b). In contrast, the 
NKG2C NK cells in the same individuals showed a charac-
teristic KIR expression pattern with variegated distribution 
of KIRs (Fig. 4 h). KIR and HLA genotyping revealed that 
the KIR expressed on the NKG2C+ NK cells was a KIR known 
to mediate NK cell licensing in four of these five patients 
(Table S2). This pattern observed may contribute to respon-
siveness to infected target cells. However, in this context, it is 
noteworthy that in models of experimental CMV infection, 
unlicensed NK cells contribute significantly to the control of 
infection (Orr et al., 2010). The observation of expression of JEM VOL. 208, January 17, 2011  19
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anti-Ki67, anti–BCL-2, or cytokines, cells were permeabilized with Cytofix/
Cytoperm (BD). Samples were acquired on a CyAn ADP nine-color flow 
cytometer (Beckman Coulter) equipped with a 25-mW 405-nm laser, a 20-mW 
488-nm laser, and a 25-mW 635-nm laser as previously described (Björkström   
et al., 2010a). Single-stained polystyrene beads (BD) were used for compen-
sation  purposes.  Software-based  compensation  was  performed  using  the 
compensation platform in FlowJo software version 8 (Tree Star, Inc.).
Infection of endothelial cells. Pooled HUVECs were grown according to 
the manufacturer’s instructions using EGM-2 BulletKit (Lonza). Before in-
fections, cells were seeded in cell culture plates and grown without supple-
menting the EGM-2 medium with hydrocortisone until 90% confluency. 
The Hantaan hantavirus (HTNV) strain 76–118 was used in the present 
study. Propagation and titration of HTNV were performed on Vero E6 cells 
as previously described (Stoltz et al., 2007). Cells were infected, or treated 
with the same amount of UV-inactivated virus as a control for nonreplicating 
virus, or with medium alone as a negative control.
Detection of virus-infected cells. At 24, 48, 72, and 96 h after HTNV in-
fection, HUVECs were fixed in methanol for 10 min at room temperature, 
followed by an incubation for 1 h at 37°C with convalescent human anti-
hantavirus serum diluted 1:40 in PBS. After rinsing three times with PBS, 
cells were incubated for 1 h at 37°C with FITC-conjugated goat anti–human 
IgG (Sigma-Aldrich) diluted 1:50 and 5 µg/ml DAPI (Sigma-Aldrich) in PBS.
KIR and HLA genotyping. Genomic DNA was isolated from 100 µl of 
peripheral  blood  using  DNase  Blood  and Tissue  KIT  (QIAGEN).  KIR  
genotyping was done as previously described using PCR-SPP technology 
and a KIR typing kit (Olerup SPP; Fauriat et al., 2008). The KIR ligand -Bw4, 
-Cw3 (C1), and -Cw4 (C2) motifs were determined using the KIR HLA li-
gand kit (Olerup-SPP).
Cell lines and surface stabilization of HLA-E. K562 cells transfected 
with HLA-E*01033 (K562-E; provided by K. Söderström, Novo Nordisk   
A/S,  Copenhagen,  Denmark)  were  maintained  in  RPMI  1640  medium   
supplemented  with  100  µg/ml  l-glutamine,  10%  heat-inactivated  FCS,   
100 U/ml penicillin G, 100 µg/ml streptomycin, and 1 mg/ml geneticin.   
Before functional experiments with K562-E cells, HLA-E expression was 
stabilized by pulsing with 100 µM of the synthetic HLA-G*0101 signal pep-
tide VMAPRTLFL at 26°C and 5% CO2 for 15 h.
NK cell functional assays. PBMCs were thawed and rested overnight in 
complete medium at a concentration of 106 cells/ml in 37°C and 5% CO2. The 
next day, 0.2 × 106 PBMCs were mixed with target cells at a ratio of 10:1 in   
V-bottom 96-well plates in a final volume of 200 µl and incubated for 6 h   
at  37°C  in  5%  CO2. When  intracellular  cytokine  staining  was  performed, 
Brefeldin A (GolgiPlug; BD) was included at a dilution of 1:250 after 1 h of co-
culture. After incubation, cells were surface stained and evaluated for CD107a, 
IFN-, and TNF expression as previously described (Bryceson et al., 2010).
NK cell proliferation assay. To assess cytokine and/or HLA-E–induced 
proliferation  of  NKG2C+  cells,  NK  cells  were  isolated  from  PBMC  of 
healthy individuals using an NK cell isolation kit (Miltenyi Biotec), labeled 
with CellTrace violet (Invitrogen), and incubated for 7 d with irradiated (90 Gy) 
K562 cells or K562*HLA-E cells (NK cell to target cell ratio of 1:1) in the 
presence or absence of 20 ng/ml human recombinant IL-15 (PeproTech). Prolif-
eration was assessed by analyzing dilution of CellTrace violet in NKG2C+ 
CD56dim NK cells by flow cytometry. The K562*HLA-E transfectant (clone 
2B4), constitutively expressing stabilized HLA-E (Falk et al., 2002), was pro-
vided by C.S. Falk (University of Heidelberg, Heidelberg, Germany).
Statistics. Data were statistically analyzed using Prism software (GraphPad 
Software, Inc.). P-values of <0.05 were considered significant. For compari-
sons between groups having <15 observations, nonparametric statistical tests 
were used, for example, the Mann Whitney test. For comparisons between 
Sun et al., 2009), one may speculate that some NKG2C+ NK 
cells in CMV-positive individuals harbor such features and are 
among the cells that rapidly proliferate in response to hanta-
virus infection. The present observations suggest that the   
human NK cell population inherently may possess features 
not classically attributed to the innate immune response (Sun 
and Lanier, 2009), including long-term persistence of specific 
subsets of cells and, possibly, memory-like features. Whether 
this represents an adaptation of the NK cell repertoire to fu-
ture infections with the same or similar pathogens is unclear. 
Given the fact that NK cells are parts of the innate immune 
system, these findings merit redefinition of the possible fea-
tures of an innate immune response.
MATERIALS AND METHODS
Study design and human material. Peripheral blood was prospectively 
obtained from 16 patients infected with hantavirus. The following inclusion 
criteria were used: (a) Verified diagnosis of acute hantavirus infection. Infec-
tion was verified by an immunofluorescence test for hantavirus-reactive IgM 
and IgG antibodies in sera from the patients or viral load quantification by 
real-time PCR from patient plasma as previously described (Evander et al., 
2007). (b) Access to a first sample drawn at an early time point after symptom 
debut (typically 3–5 d). (c) Sequential acquisition of peripheral blood during 
acute and convalescent phases of infection according to a defined sampling 
schedule with weekly samples taken during the first three weeks and later 
follow up samples. 35 uninfected blood donors, age- and sex-matched with 
the infected patients, were included as a control cohort. For isolation of 
PBMC, whole blood from infected patients was collected in CPT tubes 
(BD), centrifuged, and washed. PBMCs were frozen in 90% human albumin 
(Octapharma), 10% DMSO (WAK-Chemie Medical), and 50 IE heparin 
(LEO Pharma) and stored at 150°C for later analysis. The study was ap-
proved by the Regional Ethics Committee of Umeå University (approval 
number 04-113M). Written and oral informed consent was obtained from all 
study subjects. All clinical data, including lymphocyte count, were obtained 
through standard clinical procedures.
Antibodies for flow cytometry. The following mAbs were used: anti-
CD3 Pacific blue and anti-CD3 Cascade yellow (Dako); anti-CD56 PE-Cy7, 
anti-CD14 APC-Cy7, anti-CD16 Pacific blue, anti-CD4 biotin, anti-Ki67 
FITC, anti-Bcl-2 PE, anti–ICAM-1 PE, anti-KIR3DL1 (Dx9 clone) FITC, 
anti-CD107a FITC, and anti-CD19 APC-Cy7 (BD); anti-CD4 biotin, visu-
alized with Streptavidin Qdot 605 (Invitrogen); anti-KIR3DL1 (Dx9 clone) 
Alexa Fluor 700 (BioLegend); anti-NKG2A, anti-KIR2DL1/S1 (EB6 clone) 
APC, and anti-CD155 (Beckman Coulter); anti-NKG2A, conjugated with 
Pacific blue using a mAb labeling kit (Invitrogen); anti-KIR2DL2/S2/2DL3 
(Gl183 clone; Beckman Coulter), biotinylated with FluoReporter Mini- 
Biotin-XX Protein Labeling kit (Invitrogen) and detected with Streptavidin 
PerCP (BD); anti-NKG2C PE, anti-MICA, anti-MICB, anti-ULBP1, anti-
ULBP2, anti-ULBP3, anti-ULBP4, anti-KIR2DL3 (180701 clone) FITC, 
and anti-KIR2DL1 (143211 clone) FITC (R&D Systems); anti–HLA-E 
(eBioscience); and anti-CD112 (RDI). Intracellular cytokines were visual-
ized with anti-TNF Alexa Fluor 647 (eBioscience) and anti–IFN- FITC 
(BD).  HLA-A2  expression  was  evaluated  with  anti–HLA-A2  PE  (clone 
BB7.2; BD) and HLA-C expression was evaluated with the L31 hybridoma 
(provided by L. Berg, Karolinska Insitutet, Stockholm, Sweden) after acid-
wash treatment of the cells. Unconjugated mABs were visualized using a sec-
ondary APC mAB (BD). CD8 T cells specific for CMV were identified and 
enumerated using APC-conjugated HLA-A2 tetrameric complexes refolded 
with the CMV pp65 epitope NLVPMVATV (Beckman Coulter).
Flow cytometry. Cell surface staining of purified PBMC or HUVECs   
(human umbilical cord endothelial cells; Lonza) was performed as previously 
described (Björkström et al., 2010a). For intracellular staining of PBMC with 20 Human NK cell response to acute hantavirus infection | Björkström et al.
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